Organizing Multivalency in Carbohydrate Recognition Cite This: Chem
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
CV Otto Diels
Curriculum Vitae Prof. Dr. Otto P. H. Diels Name: Otto Paul Hermann Diels Lebensdaten: 23. Januar 1876 – 7. März 1954 Otto Diels war ein deutscher Chemiker. Für die auch nach ihm benannte Diels‐Alder‐Reaktion (auch Diensynthese genannt) erhielt er 1950 gemeinsam mit seinem Schüler Kurt Alder den Nobelpreis für Chemie. Gemeinsam mit Emil Abderhalden arbeitete er über Gallensteine und begann, sich mit Cholesterin zu beschäftigen. Darüber hinaus trägt die Diels‐Säure seinen Namen, eine von ihm bei der Strukturaufklärung der Steroide synthetisierte Dicarbonsäure. Akademischer und beruflicher Werdegang Otto Diels studierte ab 1895 an der Universität Berlin die Fächer Chemie, Physik, Botanik, Mineralogie und Philosophie. Er wurde im Sommer 1899 beim späteren Nobelpreisträger für Chemie, Emil Fischer, mit einer Arbeit über Cyanur‐Verbindungen promoviert. Im selben Jahr wurde er Assistent am Chemischen Institut der Universität Berlin. 1904 folgte die Habilitation. 1913 wurde er im selben Institut Abteilungsvorsteher. 1914 wurde er an der Universität Berlin zum außerordentlichen Professor ernannt. Zwei Jahre später nahm er einen Ruf nach Kiel an. Dort wurde er Professor für Chemie und Direktor des Chemischen Instituts und fungierte im akademischen Jahr 1925/26 als Rektor der Kieler Universität. Er blieb seiner Alma mater bis an sein Lebensende treu, trotz mehrfacher Berufungen an andere Hochschulen, darunter nach Gießen und Berlin. Nobelpreis für Chemie 1950 Bereits 1911 begann Diels, den Azodicarbonsäurediethylester zu untersuchen. Diese kurz „Azoester“ genannte Verbindung führte ihn schließlich zu seinem wichtigsten Arbeitsgebiet, der Untersuchung der Dien‐Synthese, wie die Reaktion eines Diens mit einem reaktiven Alken oder Alkin zunächst genannt wurde. Einzelne Experimente, die Diels schließlich als Dien‐Synthesen erkannte, waren bereits kurz nach der Jahrhundertwende veröffentlicht worden. -
(12) United States Patent (10) Patent No.: US 8,822,539 B2 Jensen (45) Date of Patent: Sep
USOO8822.539B2 (12) United States Patent (10) Patent No.: US 8,822,539 B2 Jensen (45) Date of Patent: Sep. 2, 2014 (54) COMBINATION THERAPIES: INHIBITORS Bialer et al., “Progress report on new antiepileptic drugs: a Summary OF GABA TRANSAMINASE AND NKCC1 of the Seventh Eilat Conference (EILATVII).” Epilepsy Res., 61:1- 48, 2004 (Abstract only). (75) Inventor: Frances E. Jensen, Boston, MA (US) Clift and Silverman, “Synthesis and Evaluation of Novel Aromatic Substrates and Competitive Inhibitors of GABA Aminotransferase.” (73) Assignee: Children's Medical Center Bioorg. Med. Chem. Left., 18:3122-3125, 2008. Crewther et al., “Potassium Channel and NKCC Cotransporter Corporation, Boston, MA (US) Involvement in Ocular Refractive Control Mechanisms. PlosOne, 3:e2839, 2008. (*) Notice: Subject to any disclaimer, the term of this Cubells et al., “In vivo action of enzyme-activated irreversible inhibi patent is extended or adjusted under 35 tors of glutamic acid decarboxylase and gamma-aminobutyric acid U.S.C. 154(b) by 149 days. transaminase in retina vs. brain.” J. Pharmacol. Exp. Ther. 238:508 514, 1986 (Abstract only). (21) Appl. No.: 13/069,311 Duboc et al., “Vigabatrin, the GABA-transaminase inhibitor, dam ages cone photoreceptors in rats.” Ann. Neurol. 55:695-705, 2004 (22) Filed: Mar 22, 2011 (Abstract only). Dzhala et al., “Bumetanide enhances phenobarbital efficacy in a (65) Prior Publication Data neonatal seizure model.” Ann. Neurol. 63:222-235, 2008 (Abstract US 2011/0237554 A1 Sep. 29, 2011 only). Dzhala et al., “NKCC1 transporter facilitates seizures in the devel oping brain.” Nature Med., 11:1205-1213, 2005 (Abstract only). Follett et al., “Glutamate Receptor-Mediated Oligodendrocyte Tox Related U.S. -
The Syntheses of Β-Lactam Antibiotics from 3-Formylcephalosporins As the Key-Intermediates
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/19082 Please be advised that this information was generated on 2021-10-03 and may be subject to change. The Syntheses of β-Lactam Antibiotics from 3-Formylcephalosporins as the Key-intermediates Een wetenschappelijke proeve op het gebied van de Natuurwetenschappen, Wiskunde en Informatica Proefschrift ter verkrijging van de graad van doctor aan de Katholieke Universiteit Nijmegen, volgens besluit van het College van Decanen in het openbaar te verdedigen op woensdag 6 februari 2002 des namiddags om 1.30 uur precies door Rolf Keltjens Geboren op 9 april 1972 te Horst Promotor Prof. dr. B. Zwanenburg Copromotor Dr. A.J.H. Klunder Manuscriptcommissie Dr. E. de Vroom (DSM Anti-Infectives, Delft) Dr. J. Verweij (voorheen DSM Anti-Infectives, Delft) Prof. dr. ir. J.C.M. van Hest The research described in this PhD thesis was part of the Cluster Project "Fine- Chemistry" and was financially supported by DSM (Geleen, The Netherlands) and the Dutch Ministry of Economical Affairs (Senter). ISBN 90-9015389-6 Omslag: Penicillium chrysogenum (copyright DSM N.V.) "Experiment is the sole interpreter of the artifices of Nature" Leonardo da Vinci (1452-1519) Aan mijn ouders Paranimfen René Gieling Sander Hornes VOORWOORD Als het manuscript nagenoeg gereed is en het geheel klaar is voor verzending naar de drukker, is het ook de hoogste tijd om de mensen met wie je vier jaar lang intensief hebt samengewerkt te bedanken. -
1 Abietic Acid R Abrasive Silica for Polishing DR Acenaphthene M (LC
1 abietic acid R abrasive silica for polishing DR acenaphthene M (LC) acenaphthene quinone R acenaphthylene R acetal (see 1,1-diethoxyethane) acetaldehyde M (FC) acetaldehyde-d (CH3CDO) R acetaldehyde dimethyl acetal CH acetaldoxime R acetamide M (LC) acetamidinium chloride R acetamidoacrylic acid 2- NB acetamidobenzaldehyde p- R acetamidobenzenesulfonyl chloride 4- R acetamidodeoxythioglucopyranose triacetate 2- -2- -1- -β-D- 3,4,6- AB acetamidomethylthiazole 2- -4- PB acetanilide M (LC) acetazolamide R acetdimethylamide see dimethylacetamide, N,N- acethydrazide R acetic acid M (solv) acetic anhydride M (FC) acetmethylamide see methylacetamide, N- acetoacetamide R acetoacetanilide R acetoacetic acid, lithium salt R acetobromoglucose -α-D- NB acetohydroxamic acid R acetoin R acetol (hydroxyacetone) R acetonaphthalide (α)R acetone M (solv) acetone ,A.R. M (solv) acetone-d6 RM acetone cyanohydrin R acetonedicarboxylic acid ,dimethyl ester R acetonedicarboxylic acid -1,3- R acetone dimethyl acetal see dimethoxypropane 2,2- acetonitrile M (solv) acetonitrile-d3 RM acetonylacetone see hexanedione 2,5- acetonylbenzylhydroxycoumarin (3-(α- -4- R acetophenone M (LC) acetophenone oxime R acetophenone trimethylsilyl enol ether see phenyltrimethylsilyl... acetoxyacetone (oxopropyl acetate 2-) R acetoxybenzoic acid 4- DS acetoxynaphthoic acid 6- -2- R 2 acetylacetaldehyde dimethylacetal R acetylacetone (pentanedione -2,4-) M (C) acetylbenzonitrile p- R acetylbiphenyl 4- see phenylacetophenone, p- acetyl bromide M (FC) acetylbromothiophene 2- -5- -
A Nobel Synthesis
MILESTONES IN CHEMISTRY Ian Grayson A nobel synthesis IAN GRAYSON Evonik Degussa GmbH, Rodenbacher Chaussee 4, Hanau-Wolfgang, 63457, Germany he first Nobel Prize for chemistry was because it is a scientific challenge, as he awarded in 1901 (to Jacobus van’t Hoff). described in his Nobel lecture: “The synthesis T Up to 2010, the chemistry prize has been of brazilin would have no industrial value; awarded 102 times, to 160 laureates, of whom its biological importance is problematical, only four have been women (1). The most but it is worth while to attempt it for the prominent area for awarding the Nobel Prize sufficient reason that we have no idea how for chemistry has been in organic chemistry, in to accomplish the task” (4). which the Nobel committee includes natural Continuing the list of Nobel Laureates in products, synthesis, catalysis, and polymers. organic synthesis we arrive next at R. B. This amounts to 24 of the prizes. Reading the Woodward. Considered by many the greatest achievements of the earlier organic chemists organic chemist of the 20th century, he who were recipients of the prize, we see that devised syntheses of numerous natural they were drawn to synthesis by the structural Alfred Nobel, 1833-1896 products, including lysergic acid, quinine, analysis and characterisation of natural cortisone and strychnine (Figure 1). 6 compounds. In order to prove the structure conclusively, some In collaboration with Albert Eschenmoser, he achieved the synthesis, even if only a partial synthesis, had to be attempted. It is synthesis of vitamin B12, a mammoth task involving nearly 100 impressive to read of some of the structures which were deduced students and post-docs over many years. -
Light and Electron Microscope Evidence for Involvement of Neuroglia (Cerebellum/Cyclic AMP/Y-Aminobutyric Acid/Harmaline/Diazepam) V
Proc. Natl. Acad. Sci. USA Vol. 76, No. 3, pp, 1485-1488, March 1979 Neurobiology Immunocytochemical localization of cyclic GMP: Light and electron microscope evidence for involvement of neuroglia (cerebellum/cyclic AMP/y-aminobutyric acid/harmaline/diazepam) V. CHAN-PALAY* AND S. L. PALAYt Departments of *Neurobiology and tAnatomy, Harvard Medical School, Boston, Massachusetts 02115 Contributed by Sanford L. Palay, December 7, 1978 ABSTRACT Guanosine 3',5'-cyclic monophosphate (cGMP) presents cytopharmacological evidence from immunocyto- immunoreactivity in the rat's cerebellum was studied with light chemistry for the cellular and subcellular location of cGMP in and electron microscopy by the indirect fluorescence method some cerebellar neurons and particularly in neuroglial cells. and the peroxidase-antiperoxidase method. Labeled cells in- cluded neuroglial cells in the cerebellar cortex, white matter, and deep nuclei; some stellate and basket cells in the cortex; and MATERIALS AND METHODS some large neurons in the deep nuclei. No evidence was found Adult 200-300 g Sprague-Dawley rats, the indirect immu- for sagittal microzonation in the cGMP distribution. In the la- nofluorescence method (11), and the peroxidase-antiperoxidase beled cells, cGMP immunoreactive sites were localized to sur- face membranes, organelles, and the cytoplasmic matrix. (PAP) method (12) for light and electron microscopy were used. Specificity was indicated by the same pattern of labeling after Rabbit antisera were raised against the 2'-O-succinyl derivative treatment with cGMP immunoglobulin that had been adsorbed of cGMP or cAMP conjugated to limpet hemocyanin (13). More with adenosine 3',5'-cyclic monophosphate (cAMP) and by the than 50% of 2'-O-succinyl-cGMP ([125I]iodotyrosine methyl failure to label after treatment with normal rabbit sera or with ester derivative) or 2'-O-succinyl-cAMP ([1251]iodotyrosine cGMP immunoglobulin that had been adsorbed with 1 mM methyl ester derivative) (<0.01 pmol) was bound at a serum cGMP. -
Increase in the Bmax of Y-Aminobutyric Acid-A Recognition Sites in Brain Regions of Mice Receiving Diazepam
Proc. Nati. Acad. Sci. USA Vol. 81, pp. 2247-2251, April 1984 Neurobiology Increase in the Bmax of y-aminobutyric acid-A recognition sites in brain regions of mice receiving diazepam (muscimol/-aminobutyric acid receptors/benzodiazepine receptors/locomotor activity) P. FERRERO, A. GuIDOTTI, AND E. COSTA* Laboratory of Preclinical Pharmacology, National Institute of Mental Health, Saint Elizabeths Hospital, Washington, DC 20032 Contributed by E. Costa, December 12, 1983 ABSTRACT y-Aminobutyric acid (GABA) receptors were MATERIALS AND METHODS characterized in vivo by studying ex vivo the binding of [3H]Muscimol (New England Nuclear) labeled on the meth- [3H]muscimol to cerebellum, cortex, hippocampus, and cor- ylene side-chain (specific activity, 29.4 Ci/mmol; 1 Ci = 37 pus striatum of mice receiving intravenous injections of tracer GBq) was injected into the tail vein of female mice (20-25 g). doses of high-specific-activity (-30 Ci/mmol) [3H]muscimol. Routinely, the dose of [3H]muscimol injected was 5 uCi per This ligand binds with high affinity (apparent Kd, 2-3 x 10-9 20 g of body weight in 0.2 ml of saline. This radiolabeled M) to a single population of binding sites (apparent Bmax, 250- ligand dose was administered either alone or with various 180 fmol per 10 mg of protein). Pharmacological studies using doses of unlabeled muscimol. In some experiments, drugs that selectively bind to GABAA or GABAB receptors [3H]muscimol was injected into cerebral ventricles through a suggest that [3H]muscimol specifically labels a GABAA recog- polyethylene cannula chronically implanted (13). The dissec- nition site. Moreover, diazepam (1.5 ,umol/kg, i.p.) increases tion of the different brain areas (cerebellum, cortex, stria- the Bmax but fails to change the affinity of [3Hlmuscimol bind- tum, and hippocampus) was carried out on a chilled (00C) ing to different brain areas. -
Pharmacological Studies on a Locust Neuromuscular Preparation
J. Exp. Biol. (1974). 6i, 421-442 421 *&ith 2 figures in Great Britain PHARMACOLOGICAL STUDIES ON A LOCUST NEUROMUSCULAR PREPARATION BY A. N. CLEMENTS AND T. E. MAY Woodstock Research Centre, Shell Research Limited, Sittingbourne, Kent {Received 13 March 1974) SUMMARY 1. The structure-activity relationships of agonists of the locust excitatory neuromuscular synapse have been reinvestigated, paying particular attention to the purity of compounds, and to the characteristics and repeatability of the muscle response. The concentrations of compounds required to stimu- late contractions of the retractor unguis muscle equal in force to the neurally evoked contractions provided a measure of the relative potencies. 2. Seven amino acids were capable of stimulating twitch contractions, glutamic acid being the most active, the others being analogues or derivatives of glutamic or aspartic acid. Aspartic acid itself had no excitatory activity. 3. Excitatory activity requires possession of two acidic groups, separated by two or three carbon atoms, and an amino group a to a carboxyl. An L-configuration appears essential. The w-acidic group may be a carboxyl, sulphinyl or sulphonyl group. Substitution of any of the functional groups generally causes total loss of excitatory activity, but an exception is found in kainic acid in which the nitrogen atom forms part of a ring. 4. The investigation of a wide variety of compounds revealed neuro- muscular blocking activity among isoxazoles, hydroxylamines, indolealkyl- amines, /?-carbolines, phenazines and phenothiazines. No specific antagonist of the locust glutamate receptor was found, but synaptic blocking agents of moderately high activity are reported. INTRODUCTION The study of arthropod neuromuscular physiology has been impeded by the lack of an antagonist which can be used to block excitatory synaptic transmission by a specific postsynaptic effect. -
Toxicol Rev 2004; 23 (1): 21-31 GHB SYMPOSIUM 1176-2551/04/0001-0021/$31.00/0
Toxicol Rev 2004; 23 (1): 21-31 GHB SYMPOSIUM 1176-2551/04/0001-0021/$31.00/0 2004 Adis Data Information BV. All rights reserved. γ-Butyrolactone and 1,4-Butanediol Abused Analogues of γ-Hydroxybutyrate Robert B. Palmer1,2 1 Toxicology Associates, Prof LLC, Denver, Colorado, USA 2 Rocky Mountain Poison & Drug Center, Denver, Colorado, USA Contents Abstract ................................................................................................................21 1. Clinical Effects .......................................................................................................23 2. Diagnosis and Management ..........................................................................................25 3. Withdrawal ..........................................................................................................26 4. Conclusion ..........................................................................................................29 Abstract γ-Hydroxybutyrate (GHB) is a GABA-active CNS depressant, commonly used as a drug of abuse. In the early 1990s, the US Drug Enforcement Administration (DEA) warned against the use of GHB and restricted its sale. This diminished availability of GHB caused a shift toward GHB analogues such as γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) as precursors and surrogates. Both GBL and 1,4-BD are metabolically converted to GHB. Furthermore, GBL is commonly used as a starting material for chemical conversion to GHB. As such, the clinical presentation and management of GBL and 1,4-BD -
Safety Review of Gamma-Aminobutyric Acid (GABA)
nutrients Review United States Pharmacopeia (USP) Safety Review of Gamma-Aminobutyric Acid (GABA) Hellen A. Oketch-Rabah 1,*, Emily F. Madden 1, Amy L. Roe 2 and Joseph M. Betz 3 1 U.S. Pharmacopeial Convention, 12601 Twinbrook Parkway, Rockville, MD 20852, USA; [email protected] 2 The Procter & Gamble Company, Cincinnati, OH 45202, USA; [email protected] 3 Office of Dietary Supplements, National Institutes of Health, Bethesda, MD 20892, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-301-230-3249 Abstract: Gamma-amino butyric acid (GABA) is marketed in the U.S. as a dietary supplement. USP conducted a comprehensive safety evaluation of GABA by assessing clinical studies, adverse event information, and toxicology data. Clinical studies investigated the effect of pure GABA as a dietary supplement or as a natural constituent of fermented milk or soy matrices. Data showed no serious adverse events associated with GABA at intakes up to 18 g/d for 4 days and in longer studies at intakes of 120 mg/d for 12 weeks. Some studies showed that GABA was associated with a transient and moderate drop in blood pressure (<10% change). No studies were available on effects of GABA during pregnancy and lactation, and no case reports or spontaneous adverse events associated with GABA were found. Chronic administration of GABA to rats and dogs at doses up to 1 g/kg/day showed no signs of toxicity. Because some studies showed that GABA was associated with decreases Citation: Oketch-Rabah, H.A.; in blood pressure, it is conceivable that concurrent use of GABA with anti-hypertensive medications Madden, E.F.; Roe, A.L.; Betz, J.M. -
Hermann Emil Fischer: Life and Achievements
GENERAL ARTICLE Hermann Emil Fischer: Life and Achievements G Nagendrappa Emil Fischer, considered as one of the greatest chemists of all times, carried out much of the fundamental work on purines, sugars, proteins, stereochemistry and several other areas of chemistry during the late nineteenth and early twentieth century. Because most of these are biological molecules, he is known as the ‘Father of Biochemistry’. His achievements in G Nagendrappa was a Professor of Organic chemical synthesis and analytical skills were much ahead of Chemistry at Bangalore his times. He was the second to get the Nobel Prize in Chem- University, and Head of istry in 1902. the Department of Medicinal Chemistry, Sri Introduction Ramachandra (Medical) University, Chennai. He is Carbohydrates, proteins, fats, and nucleic acids are the four major currently in Jain Univer- sity, Bangalore. He chemical constituents of living organisms. These four classes of continues to teach and do organic compounds are the main players in the emergence and research. His work is in existence of life. Extensive pioneering contributions to the devel- the area of organosilicon opment of all these areas of organic chemistry and biochemistry chemistry, synthetic and mechanistic organic were made by Emil Fischer through his more than four decades of chemistry, and clay- brilliant research work starting from the early 1870s. His uncanny catalysed organic reactions skills in analytical and synthetic work, his extraordinary under- (Green Chemistry). standing of the enormous amount of experimental results and their correct interpretation laid a solid foundation for the chemis- try of these biologically important molecules. Though his work essentially constituted analytical and synthetic organic chemis- try, its reach extended to other areas, particularly stereochemis- try, biochemistry, physiology and medicine. -
Ion Transport Across Membranes Mediated by a Dynamic Combinatorial Library
Ion Transport across Membranes Mediated by a Dynamic Combinatorial Library Dissertation Zur Erlangung des Doktorgrades der Mathematisch-Naturwissenschaftlichen Fakultät der Christian-Albrechts-Universität zu Kiel vorgelegt von Vittorio Saggiomo Kiel 2010 Referent: Prof. Dr. Ulrich Lüning Korreferent: Prof. Dr. Rainer Herges Tag der mündlichen Prüfung: 29 / 04 / 2010 Zum Druck genehmigt: 25 / 05 /2010 gez. Prof. Dr. L. Kipp, Dekan Die vorliegende Arbeit wurde unter Anleitung von Prof. Dr. Ulrich Lüning am Otto-Diels-Institut für Organische Chemie der Christian-Albrechts-Universität zu Kiel in der Zeit von Mai 2007 bis März 2010 angefertigt. “The true delight is in the finding out rather than in the knowing.” Isaac Asimov (Chemist) Acknowledgment First of all to my ex-girlfriend (a.k.a. wife) Ilaria who is always encouraging and supporting me in almost everything I am doing. She is following me in the foolish idea of doing research somewhere else in the world. A huge thanks to my Ph.D. supervisor Prof. Dr. Ulrich Lüning, in these three years I learned more than I expected. I have learned great lessons not only in chemistry but also in “real” life. It will be hard to find another kind supervisor like him. Thanks to Angelika Merten who took care of burEaUcracy on my behalf. That was not an easy job. A sincere thanks to all the working group. The passage from Italy to Germany was not so traumatic as I thought, mainly thanks to the kindness of all of them. In these three years I met very good friends. There are too many reasons to thanks Frank Schleef that I should write another three theses only to have three new pages for acknowledging him.